Scientists patent molecule for potentially safer diabetes drug. A team of scientists from United Institute of Pharmacy (UIP), Naini, Prayagraj, has synthesised a new active molecule, which when used in the formulation of new anti-diabetic medicine may offer better results compared to the conventional anti-diabetic medicines.
Experts at United Institute of Pharmacy have synthesized a new active molecule for anti-diabetic medicine with reduced side effects. Patent granted by government of India.